U-Blot® Research Grade GomiliximabCat. No. WA2932$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade GomiliximabCat. No. WA2932
U-Blot® Research Grade GolocdacimabCat. No. WA2931
U-Blot® Research Grade GolimumabCat. No. WA2930
U-Blot® Research Grade GoflikiceptCat. No. WA2929
U-Blot® Research Grade GocatamigCat. No. WA2928
U-Blot® Research Grade GocatamigCat. No. WA2927
U-Blot® Research Grade GlutazumabCat. No. WA2926
U-Blot® Research Grade GLP1-like peptide conjugated to Anti-Human GIPR Antibody (AMG 133)Cat. No. WA2925
U-Blot® Research Grade GlofitamabCat. No. WA2924
U-Blot® Research Grade GlenzocimabCat. No. WA2923
U-Blot® Research Grade GlembatumumabCat. No. WA2922
U-Blot® Research Grade glarivibartCat. No. WA2921